Значения термина advanced neoplasia на английском

Few prospective risk prediction models exist for advanced neoplasia (AN) in true average-risk individuals.

The principal outcome from the analysis was the cost per additional advanced neoplasia (AN) detected.

Factors associated with presence of advanced neoplasia were total number of polyps and presence of right-sided lesions.

Overall, few studies reported metachronous advanced neoplasia and no studies evaluated whether routine surveillance colonoscopy decreases risk of CRC.

Relative risks for advanced neoplasia within 5.5 years were calculated.

Patients with three or more biopsies demonstrating LGD at a single colonoscopy were at increased risk for progression to advanced neoplasia.

We conducted a prospective study to measure incidence of advanced neoplasia in patients within 5.5 years of screening colonoscopy.

We hypothesised that the risks for metachronous advanced neoplasia (AN) among patients with low-risk adenomas differ based on clinical factors distinct from those currently used.

Conclusion Advanced neoplasia was found to develop infrequently after detection of LGD in patients undergoing endoscopic surveillance for IBD.